Key result
Cerebral embolic protection during TAVI is discussed regarding its role in preventing early postprocedural stroke, which currently has an incidence of approximately 2%.
Answers are grounded in this paper and cite their sources.
Discusses the pathophysiology and incidence of stroke following TAVI, highlighting the challenges and unmet expectations of cerebral embolic protection devices.
Stroke is a devastating complication of transcatheter aortic-valve implantation (TAVI), compromising its remarkable improvements in survival and quality of life. Although TAVI-related stroke has become relatively uncommon in contemporary practice, with the incidence of early postprocedural stroke hovering around 2%, 1 it continues to adversely affect outcomes, increasing mortality, disability, and the use of health care resources. The pathophysiological features of stroke after TAVI are complex and multifaceted. 2 Early periprocedural events are largely embolic and procedural in origin, often arising from manipulation of heavily calcified aortic valves or the aorta. Embolization may entail dislodgment of thrombotic, atheromatous, or valvular debris during . . .
No takes yet. Share an insight, caveat, or question.
Hani Jneid (2025) conducted an editorial in Stroke after transcatheter aortic-valve implantation (TAVI). Cerebral embolic protection was evaluated. Cerebral embolic protection during TAVI is discussed regarding its role in preventing early postprocedural stroke, which currently has an incidence of approximately 2%.
Synapse has enriched 10 related papers. Consider them for comparative context: